Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?

Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.. Clin

Independent and Tissue Specific Prognostic Impact of miR-126 in Non-Small Cell Lung Cancer: Co-expression with Vascular Endothelial Growth Factor-A Predicts Poor Survival..

NSCLC: non-small cell lung cancer; EGFR: epidermal growth factor receptor; DS-GPA: disease-specific graded prognostic assessment; WBRT: whole-brain radiotherapy; SFRT:

difference in disease specific survival in females and males without lymph node metastasis, where females had a much higher survival rate (70.9%) then males (45.1%) (Figure 7 and

Kaplan-Meier plots for disease-free survival (DFS), breast cancer specific survival (BCSS) and overall survival (OS) according to the results of the combination of bone

Prognostic impact of CXCL16 and CXCR6 in non- small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.. Stromal CD8+

Angio- genic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy.. The revised TNM

Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. 2016 Open Access